such measures were eased or lifted in varying degrees by different governments of various countries , states and cities throughout 2020 , but the continued spread of covid-19 and increased infection rates has caused , and may continue to cause , some jurisdictions to roll back reopening plans that had been underway and re-impose quarantines , border closures , closure of certain businesses and stay-at-home orders . it is possible that jurisdictions in which the company or its affiliates operate may reintroduce more stringent preventative or protective actions which could result in further closures of businesses . governments in certain countries such as the u.s. , canada , and those in europe have responded to the acute economic and market consequences with certain monetary and fiscal policy actions . impact on operating results during the second quarter of 2020 , the effects of the covid-19 pandemic on retail stores and the increase of costs in production and sales in the u.s. had a material impact on the rate of growth of revenue in the u.s. segment , with revenue for the segment remaining flat from the first quarter of 2020. as a result of these impacts and the expectation of future impacts , for the three months ended june 30 , 2020 , the company recorded $ 35 million of impairment charges on its u.s. reporting unit and $ 5 million on the lord jones brand ( refer to note 11 of the company 's consolidated financial statements for more information regarding intangibles assets and goodwill ) . 51 the continued negative impact on the company 's results has been as expected during the three months ended december 31 , 2020 and no further impairment charges were recorded to the u.s. reporting unit or brands as a result . the company expects revenue growth and operating results in the u.s. segment to continue to be negatively impacted as retail closures are expected to continue as a result of the pandemic . revenue and the growth in revenue in the rest of world segment was not materially impacted by the effects of covid-19 during the year ended december 31 , 2020. however , prolonged closures of retail stores due to government mandated lockdowns as well as the changes in consumer purchasing behavior in canada during the covid-19 pandemic are expected to have a negative impact on the company 's short-term revenue growth in can ada . in both segments , there were no material increases in the current expected credit loss in connection with covid-19 . the company continues to closely monitor the effects of covid-19 on its operating results . production and supply chain the company 's global production facilities currently remain operational . to comply with governmental orders or other health and safety requirements , the company has : ( i ) reduced the number of personnel working on-site at its production facilities to only the roles that are necessary to be performed on-site , ( ii ) implemented work-from-home policies for other employees whose work can be performed off-site , and ( iii ) implemented other additional health and safety measures such as , among other things , enhanced hygiene and sanitation procedures , modified work schedules and social distancing protocols at its production facilities . further , as recommended by certain jurisdictions in which it operates , the company has implemented a documented covid-19 prevention plan in these locations . the company has and will continue to act in accordance with guidance from local , federal , and international health and governmental authorities , such as any government-mandated requirements for people to wear facemasks in all indoor communal spaces or at businesses , and is prepared to make additional operational adjustments , as necessary . although the company 's production facilities currently remain operational , governmental requirements , guidance and health and safety requirements continue to evolve as governmental and health authorities respond to the spread of the virus . reopening plans in certain jurisdictions have been and may be further reversed , suspended or delayed and quarantines may be re-imposed . the company 's production facilities may experience further temporary closures or quarantines if governmental or health authorities make changes to the businesses and workforces allowed to remain operational , which would result in reduced production or suspension of production if such closures or quarantines are mandated . in addition , to the extent the company 's employees contract the virus , depending on the employee 's job duties and access to facilities , the company 's ability to keep production and manufacturing facilities open may be impacted for health and safety reasons . the impacts of certain closures or other restrictions on the conduct of business operations at the facilities of third-party manufacturers , suppliers and other vendors in the company 's supply chain have not been significant to date but remain uncertain . earlier closures at manufacturers in china in 2020 had resulted in delays of deliveries of batteries and cartridges for cannabis vaporizers and personal protective equipment , such as masks and gowns used in cronos group 's manufacturing facilities certified in accordance with good manufacturing practices ( “ gmp ” ) , from such manufacturers in china . most delays have been ameliorated as manufacturers are now operational in china but other vendors or suppliers in the company 's supply chain have been , and in the future could potentially be , impacted . closures or other restrictions on the conduct of business operations on third-party manufacturers , suppliers or vendors may cause disruption in cronos group 's supply chain . as a result of a rise in infection rates late in the fourth quarter of 2020 and in the first quarter of 2021 in the u.s. , certain contract manufacturers that manufacture u.s. hemp finished products for our u.s. business have experienced temporary closures or reductions in their operations leading to shortages of finished product available via the e-commerce channel . story_separator_special_tag impairment loss on goodwill and intangible assets for fy 2020 , we reported an impairment loss on goodwill and intangible assets of $ 40.0 million representing an increase of $ 40.0 million from fy 2019 primarily driven by a $ 35.0 million impairment charge on the u.s. reporting unit and a $ 5.0 million impairment charge on the lord jones brand during the year ended december 31 , 2020. for further information , see note 11 to the consolidated financial statements in item 8 of this annual report . gain on disposal of other investments for fy 2020 , we reported a gain on disposal of other investments of $ 4.8 million representing a decrease of $ 11.5 million from fy 2019 primarily driven by a decrease in the sale of shares associated with the whistler transaction ( as defined below ) during fy 2020 compared to fy 2019. for further information , see note 7 to the consolidated financial statements in item 8 of this annual report . financing and transaction costs for fy 2020 , we reported financing and transaction costs of $ 0.04 million representing a decrease of $ 32.2 million from fy 2019 primarily driven by the increased financing and transaction costs incurred in fy 2019 compared to fy 2020 as a result of the altria investment and the redwood acquisition . for further information see note 27 and note 14 to the consolidated financial statements in item 8 of this annual report . income tax expense for fy 2020 , we reported an income tax expense of $ 1.3 million representing an increase of $ 1.3 million from fy 2019 primarily driven by changes in valuation allowance , partially offset by a decrease in the fair value gain on financial liabilities . results of operations by business segment : fy 2020 compared with fy 2019 summary of financial results – row replace_table_token_9_th ( i ) see “ non-gaap measures ” for information related to non-gaap measures . net revenue – row replace_table_token_10_th for fy 2020 , we reported net revenue of $ 37.2 million , representing an increase of $ 16.8 million from fy 2019. this change was primarily due to : an increase in sales due to the continued growth of the adult-use market in canada and sales in the israeli medical market , partially offset by non-recurring wholesale revenue in the canadian market in fy 2019 and strategic price reductions on various adult-use cannabis products in canada in fy 2020 . 57 cost of sales and gross profit ( loss ) – row replace_table_token_11_th for fy 2020 , we reported gross loss of $ 30.0 million , representing an increase in losses of $ 10.5 million from fy 2019. this change was primarily due to : an increase in cost of sales primarily driven by third-party purchased flower associated with adult-use products in canada and a decline in wholesale sales in fy 2020. the company anticipates that gross margin will continue to fluctuate as price and mix change from quarter-to-quarter . partially offset by an increase in net revenue from fy 2019 , as described above and a decrease in inventory write-downs . we may incur further inventory write-downs due to pricing pressures in the marketplace . adjusted ebitda – row ( in thousands of u.s. dollars ) year ended december 31 , change 2020 2019 $ % adjusted ebitda $ ( 98,349 ) $ ( 84,826 ) $ ( 13,523 ) 16 % ( i ) see “ non-gaap measures ” for information related to non-gaap measures . for fy 2020 , we reported adjusted ebitda of $ ( 98.3 ) million , representing a decrease in adjusted ebitda of $ 13.5 million from fy 2019. this change was primarily due to : an increase in row gross loss from fy 2019 , as described above . an increase in r & d costs primarily related to the ginkgo strategic partnership and costs related to increased spending on product development and cannabinoid intellectual property . an increase in general and administrative costs from fy 2019 driven by an increase in salaries and wages as a result of increased headcount to support the company 's growth strategy and increased office and general expenses . an increase in sales and marketing costs primarily related to building and developing our brands and products in the canadian adult-use market . summary of financial results – u.s. replace_table_token_12_th ( i ) see “ non-gaap measures ” for information related to non-gaap measures . 58 net revenue – u.s. ( in thousands of u.s. dollars ) year ended december 31 , change 2020 2019 $ % net revenue $ 9,495 $ 3,364 $ 6,131 182 % for fy 2020 , the u.s. segment reported net revenue of $ 9.5 million , representing an increase of $ 6.1 million from fy 2019. the increase was primarily due to : an increase in sales due to a full year of u.s. segment results in fy 2020 as opposed to 117 days in fy 2019. the growth in existing product lines and introductions of new u.s. hemp-derived cbd products during fy 2020. a significant amount of the u.s. segment 's fy 2020 revenue was earned during the fourth quarter as a result of increased sales in the direct-to-consumer channel driven by holiday sales . cost of sales and gross profit – u.s. replace_table_token_13_th for fy 2020 , the u.s. segment reported gross profit of $ 4.2 million representing an increase in gross profit of $ 2.3 million from fy 2019. this was primarily due to : the increase in net revenue , as described above . partially offset by an increase in cost of sales primarily driven by a full year of u.s. segment results in fy 2020 as opposed to 117 days in the same period in 2019. adjusted ebitda – u.s. ( in thousands of u.s. dollars ) year ended december 31 , change 2020 2019 $ % adjusted

liquidity and capital resources we believe that our existing cash and cash equivalents and short-term investments will be sufficient to fund our business operations and capital expenditures over the next twelve months . liquidity our primary need for liquidity is to fund operations and capital expenditures . our ability to fund operations and capital expenditures depends on , among other things , future operating performance and cash flows that are subject to general economic conditions and financial and other factors , including factors beyond our control . 59 historically , we have primarily funded our operations through equity financing . in march 2019 , altria closed a c $ 2.4 billion ( approximately $ 1.8 billion ) investment in us , pursuant to which we issued to certain wholly owned subsidiaries of altria 149,831,154 of our common shares and one warrant , as further discussed under “ altria strategic investment ” herein . as of february 23 , 2021 , we had a cash and cash equivalents balance of $ 1.1 billion and $ 0.2 billion in short term investments to fund operations and capital expenditures . capital resources as of december 31 , 2020 , we had $ 1.1 billion in cash and cash equivalents and $ 0.2 billion in short term investments . as of december 31 , 2020 , the company had no external financing . contractual obligations as of december 31 , 2020 , the company had the following contractual obligations : replace_table_token_14_th finance lease obligations relate to equipment leases maturing in june 2022. operating lease obligations relate to land , buildings , vehicles , and office space in canada , the u.s. and israel . purchase obligations include commitments for capital expenditure , information technology services , and other professional services . other long-term liabilities relate to commitments for research and development such as ginkgo foundry access fees , as well as undrawn but committed loans to our joint ventures . summary of cash flows replace_table_token_15_th fy 2020 cash flows vs fy 2019 cash flows operating activities .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```liquidity and capital resources we believe that our existing cash and cash equivalents and short-term investments will be sufficient to fund our business operations and capital expenditures over the next twelve months . liquidity our primary need for liquidity is to fund operations and capital expenditures . our ability to fund operations and capital expenditures depends on , among other things , future operating performance and cash flows that are subject to general economic conditions and financial and other factors , including factors beyond our control . 59 historically , we have primarily funded our operations through equity financing . in march 2019 , altria closed a c $ 2.4 billion ( approximately $ 1.8 billion ) investment in us , pursuant to which we issued to certain wholly owned subsidiaries of altria 149,831,154 of our common shares and one warrant , as further discussed under “ altria strategic investment ” herein . as of february 23 , 2021 , we had a cash and cash equivalents balance of $ 1.1 billion and $ 0.2 billion in short term investments to fund operations and capital expenditures . capital resources as of december 31 , 2020 , we had $ 1.1 billion in cash and cash equivalents and $ 0.2 billion in short term investments . as of december 31 , 2020 , the company had no external financing . contractual obligations as of december 31 , 2020 , the company had the following contractual obligations : replace_table_token_14_th finance lease obligations relate to equipment leases maturing in june 2022. operating lease obligations relate to land , buildings , vehicles , and office space in canada , the u.s. and israel . purchase obligations include commitments for capital expenditure , information technology services , and other professional services . other long-term liabilities relate to commitments for research and development such as ginkgo foundry access fees , as well as undrawn but committed loans to our joint ventures . summary of cash flows replace_table_token_15_th fy 2020 cash flows vs fy 2019 cash flows operating activities .
```    
 Suspicious Activity Report : such measures were eased or lifted in varying degrees by different governments of various countries , states and cities throughout 2020 , but the continued spread of covid-19 and increased infection rates has caused , and may continue to cause , some jurisdictions to roll back reopening plans that had been underway and re-impose quarantines , border closures , closure of certain businesses and stay-at-home orders . it is possible that jurisdictions in which the company or its affiliates operate may reintroduce more stringent preventative or protective actions which could result in further closures of businesses . governments in certain countries such as the u.s. , canada , and those in europe have responded to the acute economic and market consequences with certain monetary and fiscal policy actions . impact on operating results during the second quarter of 2020 , the effects of the covid-19 pandemic on retail stores and the increase of costs in production and sales in the u.s. had a material impact on the rate of growth of revenue in the u.s. segment , with revenue for the segment remaining flat from the first quarter of 2020. as a result of these impacts and the expectation of future impacts , for the three months ended june 30 , 2020 , the company recorded $ 35 million of impairment charges on its u.s. reporting unit and $ 5 million on the lord jones brand ( refer to note 11 of the company 's consolidated financial statements for more information regarding intangibles assets and goodwill ) . 51 the continued negative impact on the company 's results has been as expected during the three months ended december 31 , 2020 and no further impairment charges were recorded to the u.s. reporting unit or brands as a result . the company expects revenue growth and operating results in the u.s. segment to continue to be negatively impacted as retail closures are expected to continue as a result of the pandemic . revenue and the growth in revenue in the rest of world segment was not materially impacted by the effects of covid-19 during the year ended december 31 , 2020. however , prolonged closures of retail stores due to government mandated lockdowns as well as the changes in consumer purchasing behavior in canada during the covid-19 pandemic are expected to have a negative impact on the company 's short-term revenue growth in can ada . in both segments , there were no material increases in the current expected credit loss in connection with covid-19 . the company continues to closely monitor the effects of covid-19 on its operating results . production and supply chain the company 's global production facilities currently remain operational . to comply with governmental orders or other health and safety requirements , the company has : ( i ) reduced the number of personnel working on-site at its production facilities to only the roles that are necessary to be performed on-site , ( ii ) implemented work-from-home policies for other employees whose work can be performed off-site , and ( iii ) implemented other additional health and safety measures such as , among other things , enhanced hygiene and sanitation procedures , modified work schedules and social distancing protocols at its production facilities . further , as recommended by certain jurisdictions in which it operates , the company has implemented a documented covid-19 prevention plan in these locations . the company has and will continue to act in accordance with guidance from local , federal , and international health and governmental authorities , such as any government-mandated requirements for people to wear facemasks in all indoor communal spaces or at businesses , and is prepared to make additional operational adjustments , as necessary . although the company 's production facilities currently remain operational , governmental requirements , guidance and health and safety requirements continue to evolve as governmental and health authorities respond to the spread of the virus . reopening plans in certain jurisdictions have been and may be further reversed , suspended or delayed and quarantines may be re-imposed . the company 's production facilities may experience further temporary closures or quarantines if governmental or health authorities make changes to the businesses and workforces allowed to remain operational , which would result in reduced production or suspension of production if such closures or quarantines are mandated . in addition , to the extent the company 's employees contract the virus , depending on the employee 's job duties and access to facilities , the company 's ability to keep production and manufacturing facilities open may be impacted for health and safety reasons . the impacts of certain closures or other restrictions on the conduct of business operations at the facilities of third-party manufacturers , suppliers and other vendors in the company 's supply chain have not been significant to date but remain uncertain . earlier closures at manufacturers in china in 2020 had resulted in delays of deliveries of batteries and cartridges for cannabis vaporizers and personal protective equipment , such as masks and gowns used in cronos group 's manufacturing facilities certified in accordance with good manufacturing practices ( “ gmp ” ) , from such manufacturers in china . most delays have been ameliorated as manufacturers are now operational in china but other vendors or suppliers in the company 's supply chain have been , and in the future could potentially be , impacted . closures or other restrictions on the conduct of business operations on third-party manufacturers , suppliers or vendors may cause disruption in cronos group 's supply chain . as a result of a rise in infection rates late in the fourth quarter of 2020 and in the first quarter of 2021 in the u.s. , certain contract manufacturers that manufacture u.s. hemp finished products for our u.s. business have experienced temporary closures or reductions in their operations leading to shortages of finished product available via the e-commerce channel . story_separator_special_tag impairment loss on goodwill and intangible assets for fy 2020 , we reported an impairment loss on goodwill and intangible assets of $ 40.0 million representing an increase of $ 40.0 million from fy 2019 primarily driven by a $ 35.0 million impairment charge on the u.s. reporting unit and a $ 5.0 million impairment charge on the lord jones brand during the year ended december 31 , 2020. for further information , see note 11 to the consolidated financial statements in item 8 of this annual report . gain on disposal of other investments for fy 2020 , we reported a gain on disposal of other investments of $ 4.8 million representing a decrease of $ 11.5 million from fy 2019 primarily driven by a decrease in the sale of shares associated with the whistler transaction ( as defined below ) during fy 2020 compared to fy 2019. for further information , see note 7 to the consolidated financial statements in item 8 of this annual report . financing and transaction costs for fy 2020 , we reported financing and transaction costs of $ 0.04 million representing a decrease of $ 32.2 million from fy 2019 primarily driven by the increased financing and transaction costs incurred in fy 2019 compared to fy 2020 as a result of the altria investment and the redwood acquisition . for further information see note 27 and note 14 to the consolidated financial statements in item 8 of this annual report . income tax expense for fy 2020 , we reported an income tax expense of $ 1.3 million representing an increase of $ 1.3 million from fy 2019 primarily driven by changes in valuation allowance , partially offset by a decrease in the fair value gain on financial liabilities . results of operations by business segment : fy 2020 compared with fy 2019 summary of financial results – row replace_table_token_9_th ( i ) see “ non-gaap measures ” for information related to non-gaap measures . net revenue – row replace_table_token_10_th for fy 2020 , we reported net revenue of $ 37.2 million , representing an increase of $ 16.8 million from fy 2019. this change was primarily due to : an increase in sales due to the continued growth of the adult-use market in canada and sales in the israeli medical market , partially offset by non-recurring wholesale revenue in the canadian market in fy 2019 and strategic price reductions on various adult-use cannabis products in canada in fy 2020 . 57 cost of sales and gross profit ( loss ) – row replace_table_token_11_th for fy 2020 , we reported gross loss of $ 30.0 million , representing an increase in losses of $ 10.5 million from fy 2019. this change was primarily due to : an increase in cost of sales primarily driven by third-party purchased flower associated with adult-use products in canada and a decline in wholesale sales in fy 2020. the company anticipates that gross margin will continue to fluctuate as price and mix change from quarter-to-quarter . partially offset by an increase in net revenue from fy 2019 , as described above and a decrease in inventory write-downs . we may incur further inventory write-downs due to pricing pressures in the marketplace . adjusted ebitda – row ( in thousands of u.s. dollars ) year ended december 31 , change 2020 2019 $ % adjusted ebitda $ ( 98,349 ) $ ( 84,826 ) $ ( 13,523 ) 16 % ( i ) see “ non-gaap measures ” for information related to non-gaap measures . for fy 2020 , we reported adjusted ebitda of $ ( 98.3 ) million , representing a decrease in adjusted ebitda of $ 13.5 million from fy 2019. this change was primarily due to : an increase in row gross loss from fy 2019 , as described above . an increase in r & d costs primarily related to the ginkgo strategic partnership and costs related to increased spending on product development and cannabinoid intellectual property . an increase in general and administrative costs from fy 2019 driven by an increase in salaries and wages as a result of increased headcount to support the company 's growth strategy and increased office and general expenses . an increase in sales and marketing costs primarily related to building and developing our brands and products in the canadian adult-use market . summary of financial results – u.s. replace_table_token_12_th ( i ) see “ non-gaap measures ” for information related to non-gaap measures . 58 net revenue – u.s. ( in thousands of u.s. dollars ) year ended december 31 , change 2020 2019 $ % net revenue $ 9,495 $ 3,364 $ 6,131 182 % for fy 2020 , the u.s. segment reported net revenue of $ 9.5 million , representing an increase of $ 6.1 million from fy 2019. the increase was primarily due to : an increase in sales due to a full year of u.s. segment results in fy 2020 as opposed to 117 days in fy 2019. the growth in existing product lines and introductions of new u.s. hemp-derived cbd products during fy 2020. a significant amount of the u.s. segment 's fy 2020 revenue was earned during the fourth quarter as a result of increased sales in the direct-to-consumer channel driven by holiday sales . cost of sales and gross profit – u.s. replace_table_token_13_th for fy 2020 , the u.s. segment reported gross profit of $ 4.2 million representing an increase in gross profit of $ 2.3 million from fy 2019. this was primarily due to : the increase in net revenue , as described above . partially offset by an increase in cost of sales primarily driven by a full year of u.s. segment results in fy 2020 as opposed to 117 days in the same period in 2019. adjusted ebitda – u.s. ( in thousands of u.s. dollars ) year ended december 31 , change 2020 2019 $ % adjusted

